PE20050941A1 - Suspensiones acuosas de ciclesonida para nebulizacion - Google Patents
Suspensiones acuosas de ciclesonida para nebulizacionInfo
- Publication number
- PE20050941A1 PE20050941A1 PE2004001247A PE2004001247A PE20050941A1 PE 20050941 A1 PE20050941 A1 PE 20050941A1 PE 2004001247 A PE2004001247 A PE 2004001247A PE 2004001247 A PE2004001247 A PE 2004001247A PE 20050941 A1 PE20050941 A1 PE 20050941A1
- Authority
- PE
- Peru
- Prior art keywords
- solution
- cyclesound
- cyclesonida
- refers
- aqueous suspension
- Prior art date
Links
- 239000000725 suspension Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 239000007900 aqueous suspension Substances 0.000 abstract 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002663 nebulization Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03028848 | 2003-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20050941A1 true PE20050941A1 (es) | 2005-11-08 |
Family
ID=34684543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2004001247A PE20050941A1 (es) | 2003-12-16 | 2004-12-10 | Suspensiones acuosas de ciclesonida para nebulizacion |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070117783A1 (enExample) |
| EP (2) | EP1697398B1 (enExample) |
| JP (1) | JP5001657B2 (enExample) |
| KR (1) | KR101086095B1 (enExample) |
| CN (1) | CN100513417C (enExample) |
| AR (1) | AR046892A1 (enExample) |
| AU (1) | AU2004298447B2 (enExample) |
| BR (1) | BRPI0416854B8 (enExample) |
| CA (1) | CA2549038C (enExample) |
| CO (1) | CO5700832A2 (enExample) |
| EA (1) | EA012388B1 (enExample) |
| EC (1) | ECSP066608A (enExample) |
| IL (1) | IL175461A (enExample) |
| MY (1) | MY159377A (enExample) |
| NO (1) | NO337225B1 (enExample) |
| NZ (1) | NZ547217A (enExample) |
| PE (1) | PE20050941A1 (enExample) |
| TW (1) | TWI350757B (enExample) |
| UA (1) | UA87123C2 (enExample) |
| WO (1) | WO2005058935A2 (enExample) |
| ZA (1) | ZA200603768B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2022796A1 (en) * | 2007-08-07 | 2009-02-11 | Nycomed GmbH | Amorphous ciclesonide |
| US7984792B2 (en) * | 2008-03-03 | 2011-07-26 | Rolls-Royce Corporation | Lubrication system |
| CN102238958A (zh) * | 2008-12-03 | 2011-11-09 | 日本株式会社Ltt生物医药 | 含有修饰型超氧化物歧化酶的吸入剂 |
| EP3311823B1 (en) | 2009-09-02 | 2020-11-25 | Synedgen, Inc. | Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds |
| DK2670242T3 (da) * | 2011-01-31 | 2022-05-02 | Avalyn Pharma Inc | Aerosolpirfenidon- og pyridonanalogforbindelser og anvendelser deraf |
| US10105356B2 (en) | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| KR20140057604A (ko) | 2011-08-12 | 2014-05-13 | 베링거잉겔하임베트메디카게엠베하 | 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제 |
| WO2013024070A1 (en) | 2011-08-18 | 2013-02-21 | Nycomed Gmbh | Pharmaceutical aerosol product for administration by oral or nasal inhalation |
| EP2756840B1 (en) | 2011-09-14 | 2020-08-19 | Shionogi & Co., Ltd. | Pharmaceutical composition for inhalation |
| LT3473255T (lt) | 2012-12-21 | 2022-03-10 | Boehringer Ingelheim Vetmedica Gmbh | Farmacinė vaisto forma, apimanti ciklezonidą |
| BR122016029247A2 (pt) * | 2012-12-21 | 2019-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonida para o tratamento de doença das vias respiratórias em cavalos e composição que a compreende |
| AU2015204558B2 (en) | 2014-01-10 | 2020-04-30 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| HUE051527T2 (hu) | 2014-06-18 | 2021-03-01 | Boehringer Ingelheim Vetmedica Gmbh | Muszkarin-antagonisták és kombinációik légúti betegség lovakban történõ kezelésére |
| WO2016040899A1 (en) * | 2014-09-11 | 2016-03-17 | Synedgen, Inc. | Compositions and methods of use thereof |
| WO2017022814A1 (ja) * | 2015-08-05 | 2017-02-09 | 第一三共株式会社 | ネブライザー用組成物 |
| CN106692163A (zh) * | 2015-11-13 | 2017-05-24 | 天津金耀集团有限公司 | 一种吸入用环索奈德混悬液组合物 |
| WO2019090405A1 (pt) * | 2017-11-11 | 2019-05-16 | Carvalho Junior Mario Virgilio De | Medicamento de ciclesonida para cura e prevenção da gripe causada pelo vírus influenza |
| US20220023282A1 (en) * | 2018-12-13 | 2022-01-27 | Mannkind Corporation | Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them |
| US20210346613A1 (en) * | 2020-05-05 | 2021-11-11 | Mahesh Kumar KHAITAN | Controlled delivery device for treating coronavirus infections and methods thereof |
| CN115835885B (zh) * | 2020-06-23 | 2025-02-07 | 广州谷森制药有限公司 | 包含奥达特罗和布地奈德的药物组合物的制备 |
| US20240358888A1 (en) * | 2021-04-01 | 2024-10-31 | Vitrean Inc. | Methods for manufacturing of highly concentrated hydrogels |
| WO2022231533A1 (en) * | 2021-04-29 | 2022-11-03 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Process for the preparation of sterilized suspensions for the inhalation by nebulization |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE458986B (sv) * | 1985-03-29 | 1989-05-29 | Draco Ab | Dosfoerpackning |
| SE8600632D0 (sv) | 1986-02-13 | 1986-02-13 | Kabivitrum Ab | Novel pharmaceutical composition |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| US5346702A (en) * | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| UA45311C2 (uk) * | 1993-04-02 | 2002-04-15 | Бік Гульден Ломберг Хеміше Фабрік Гмбх | 16<font face="Symbol">a</font>,17-ЦИКЛОГЕКСИЛМЕТИЛЕНДІОКСИ-11<font face="Symbol">b</font>,21-ДИГІДРОКСИПРЕГНА-1,4-ДІЄН-3,20-ДІОН, СПОСІБ ЙОГО ОДЕРЖАННЯ, ЛІКАРСЬКИЙ ЗАСІБ |
| US5540930A (en) * | 1993-10-25 | 1996-07-30 | Pharmos Corporation | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
| GB9410222D0 (en) | 1994-05-21 | 1994-07-06 | Glaxo Wellcome Australia Ltd | Medicaments |
| DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
| DE19541689A1 (de) | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
| DE19635498A1 (de) | 1996-09-03 | 1998-03-26 | Byk Gulden Lomberg Chem Fab | Verfahren zur Epimerenanreicherung |
| US6120752A (en) | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
| SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
| US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
| TWI243687B (en) * | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| US6264923B1 (en) | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| DE69914742T2 (de) | 1998-05-29 | 2004-11-25 | Skyepharma Canada Inc., Verdun | Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben |
| US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| IT1303692B1 (it) | 1998-11-03 | 2001-02-23 | Chiesi Farma Spa | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
| IT1313553B1 (it) * | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
| AR026073A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica acuosa que contiene ciclesonida |
| EP1142565A4 (en) | 1999-10-20 | 2004-03-17 | Teijin Ltd | AQUEOUS THERAPEUTIC COMPOSITIONS |
| AR026072A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
| DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
| DK1337279T3 (da) * | 2000-11-24 | 2006-09-25 | Breath Ltd | Sterilisation af glucocorticosteroidsuspensioner |
| US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| DE10145361A1 (de) * | 2001-09-14 | 2003-04-03 | Pari Gmbh | Verfahren zur Herstellung von flüssigen, sterilen Zubereitungen zur Inhalation |
| EP1438019A1 (en) * | 2001-10-24 | 2004-07-21 | PARI GmbH Spezialisten für effektive Inhalation | Kit for the preparation of a pharmaceutical composition |
| US8541399B2 (en) | 2002-02-19 | 2013-09-24 | Resolution Chemicals Limited | Solvent-based sterilisation of pharmaceuticals |
| ATE352564T1 (de) | 2002-03-04 | 2007-02-15 | Nymox Corp | Spheron-komponenten für die bestimmung von verbindungen, die symptome der alzheimer krankheit behandeln können, ihre behandlungen und tiermodelle |
| JP4720086B2 (ja) | 2002-04-12 | 2011-07-13 | 味の素株式会社 | 動脈硬化予防用組成物 |
| ITMI20020808A1 (it) | 2002-04-17 | 2003-10-17 | Chiesi Farma Spa | Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione |
| JP4364486B2 (ja) | 2002-07-02 | 2009-11-18 | 帝人株式会社 | 無菌水性懸濁製剤 |
| HK1080365B (zh) | 2002-07-02 | 2008-11-28 | Astrazeneca Ab | 含有环索奈德的无菌水性混悬剂 |
| US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
| PT1545548E (pt) * | 2002-08-30 | 2010-09-02 | Nycomed Gmbh | Utilização da combinação de ciclesonida e anti-histamínicos para o tratamento de rinite alérgica |
| WO2004029574A1 (ja) | 2002-09-24 | 2004-04-08 | Fujitsu Limited | 歪み波形制御装置、歪み規制部材、歪み波形制御装置の歪み波形制御方法、及び歪み波形制御プログラム |
| JP2006501936A (ja) | 2002-10-04 | 2006-01-19 | エラン ファーマ インターナショナル，リミティド | 固体ナノ粒子活性薬剤のガンマ線照射 |
| ITMI20022674A1 (it) * | 2002-12-18 | 2004-06-19 | Chiesi Farma Spa | Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione. |
| EP1454636A1 (en) | 2003-03-04 | 2004-09-08 | Dompé S.P.A. | Sterilization of glucocorticoid drug particles for pulmonary delivery |
| MY143936A (en) | 2003-03-27 | 2011-07-29 | Nycomed Gmbh | Process for preparing crystalline ciclesonide with defined particle size |
| TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| PT1670482E (pt) * | 2003-09-16 | 2014-03-12 | Takeda Gmbh | Utilização de ciclesonida para o tratamento de doenças respiratórias |
| DE10347994A1 (de) * | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
| DE602005026225D1 (de) | 2004-03-12 | 2011-03-24 | Cipla Ltd | Sterilisationsprozess für Steroide |
| GB0410995D0 (en) | 2004-05-17 | 2004-06-23 | Norton Healthcare Ltd | Heat sterilization of glucocorticosteroids |
| ITSA20040012A1 (it) | 2004-09-07 | 2004-12-07 | Genetec S P A | Processo di sterilizzazione di un glucocorticosteroide. |
| GB0425266D0 (en) | 2004-11-16 | 2004-12-15 | Norton Healthcare Ltd | Pharmaceutical manufacturing process |
-
2004
- 2004-12-10 PE PE2004001247A patent/PE20050941A1/es active IP Right Grant
- 2004-12-14 MY MYPI20045134A patent/MY159377A/en unknown
- 2004-12-15 KR KR1020067013760A patent/KR101086095B1/ko not_active Expired - Lifetime
- 2004-12-15 AU AU2004298447A patent/AU2004298447B2/en not_active Expired
- 2004-12-15 CA CA2549038A patent/CA2549038C/en not_active Expired - Fee Related
- 2004-12-15 US US10/582,499 patent/US20070117783A1/en not_active Abandoned
- 2004-12-15 EA EA200601091A patent/EA012388B1/ru not_active IP Right Cessation
- 2004-12-15 BR BRPI0416854A patent/BRPI0416854B8/pt active IP Right Grant
- 2004-12-15 UA UAA200607589A patent/UA87123C2/uk unknown
- 2004-12-15 EP EP04804847A patent/EP1697398B1/en not_active Expired - Lifetime
- 2004-12-15 NZ NZ547217A patent/NZ547217A/en not_active IP Right Cessation
- 2004-12-15 JP JP2006544438A patent/JP5001657B2/ja not_active Expired - Lifetime
- 2004-12-15 AR ARP040104661A patent/AR046892A1/es not_active Application Discontinuation
- 2004-12-15 CN CNB2004800368287A patent/CN100513417C/zh not_active Expired - Lifetime
- 2004-12-15 WO PCT/EP2004/053495 patent/WO2005058935A2/en not_active Ceased
- 2004-12-15 EP EP10173237.8A patent/EP2319858B1/en not_active Expired - Lifetime
- 2004-12-16 TW TW093139206A patent/TWI350757B/zh not_active IP Right Cessation
-
2006
- 2006-05-07 IL IL175461A patent/IL175461A/en active IP Right Grant
- 2006-05-11 ZA ZA200603768A patent/ZA200603768B/en unknown
- 2006-06-05 EC EC2006006608A patent/ECSP066608A/es unknown
- 2006-06-07 CO CO06054801A patent/CO5700832A2/es active IP Right Grant
- 2006-06-30 NO NO20063047A patent/NO337225B1/no unknown
-
2015
- 2015-09-25 US US14/865,637 patent/US11052042B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20050941A1 (es) | Suspensiones acuosas de ciclesonida para nebulizacion | |
| JP3623962B2 (ja) | ヒドロキソコバラミンの鼻中投与用医薬組成物 | |
| Pires et al. | Intranasal drug delivery: how, why and what for? | |
| BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
| SI1885336T1 (sl) | Suspenzijske formulacije, ki obsegajo aktivno sestavino, poloksamerni ali meroksapolni surfaktant in glikol, in njihova uporaba za pripravo zdravila za zdravljenje oftalmičnih motenj | |
| WO2006122318A3 (en) | Directed intranasal administration of pharmaceutical agents | |
| AR056020A1 (es) | Formulaciones liquidas | |
| DK1158959T3 (da) | Sammensætninger og fremgangsmåder til forbedret indgift af hydrofobe terapeutiske midler | |
| WO2005065646A3 (en) | Novel drug compositions and dosage forms | |
| GEP20094781B (en) | Sulfonamide derivatives for the treatment of diseases | |
| BRPI0515573A (pt) | copolìmero por blocos, preparação de micela e agente anticáncer contendo a mesma como o ingrediente ativo | |
| MX2013000001A (es) | Composición farmaceutica de liberacion prolongada y acción retardada que comprende dapoxetina para administaracion oral. | |
| AR048333A1 (es) | Metodos de tratamiento de infeccion de vih | |
| CY1108676T1 (el) | Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων | |
| BR122019027412B8 (pt) | composição farmacêutica de liberação sustentada na forma de micropartículas, processo para preparação das ditas micropartículas, e kit de administração | |
| JP4863589B2 (ja) | 水性組成物 | |
| ATE529417T1 (de) | 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält | |
| US20250213601A1 (en) | Methods and bioavailable highly permeable compounds for the treatment of viral diseases | |
| AR048324A1 (es) | Metodos para tratar infecciones por vih | |
| JP4409798B2 (ja) | 洗浄剤 | |
| JP2003206241A (ja) | 眼科用剤 | |
| JP4737911B2 (ja) | 点眼剤 | |
| WO2006072940A3 (en) | Controlled long acting release pharmaceutical preparation for use in the oral cavity | |
| JP2008189677A (ja) | 洗浄剤 | |
| JP2003146892A (ja) | 洗浄剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |